Key Points
- National Strategy: China’s government, through seven powerful departments, released “Implementation Opinions on Promoting the Innovative Development of the Brain-Computer Interface Industry” on August 8, 2025, marking a “dual-driven” push for policy and technology acceleration in BCI.
- Ambitious Goals: The plan sets clear milestones: by 2027, significant BCI technology breakthroughs and foundational systems are expected, and by 2030, China aims for global leadership in the BCI industry with 2-3 globally influential enterprises.
- Tech Focus: The strategy emphasizes accelerating R&D in implantable BCI devices (high-density sensors, ultra-low-power chips) and scaling non-implantable devices for mass consumer integration, including new form factors and smart accessories.
- Funding & Commercialization: China is committing substantial funding via national projects and funds, offering prioritized registration and insurance for new BCI technologies. Official pricing for invasive BCI implantation (e.g., ¥6,580 RMB in Zhejiang) and removal has already been established.
- Clinical Milestones: In June, China became only the second country globally (after the US) to conduct a prospective clinical trial for an implantable BCI, a collaborative effort between the Chinese Academy of Sciences and Huashan Hospital.

China’s brain-computer interface (BCI) industry just got a massive tailwind from the highest levels of government.
In a major move on August 8, 2025, seven of the country’s most powerful departments dropped a bombshell document titled the “Implementation Opinions on Promoting the Innovative Development of the Brain-Computer Interface Industry.”
Think of it as the official “construction plan” for China’s BCI future.
This isn’t just another policy paper. It’s a coordinated push from:
- The Ministry of Industry and Information Technology
- The National Development and Reform Commission
- The Ministry of Education
- The National Health Commission
- The State-owned Assets Supervision and Administration Commission
- The Chinese Academy of Sciences
- The National Medical Products Administration
The core message? Policy and technology are now “dual-driven,” with a huge emphasis on accelerating breakthroughs in implantable BCI devices and fast-tracking them to market.
Let’s break down what this actually means.

Resume Captain
Your AI Career Toolkit:
- AI Resume Optimization
- Custom Cover Letters
- LinkedIn Profile Boost
- Interview Question Prep
- Salary Negotiation Agent

China’s BCI Roadmap: The 2027 and 2030 Goals
The government has laid out a clear, two-stage timeline. No vague promises here.
By 2027: Building the Foundation
- Achieve significant breakthroughs in key BCI technologies.
- Establish a preliminary technical, industrial, and standards system.
- Bring the performance of core components like electrodes, chips, and complete BCI products to “international advanced levels.”
- See BCI products applied in industrial manufacturing, healthcare, and consumer lifestyle sectors.
- Foster 2 to 3 dedicated BCI industrial development clusters.
- Explore and launch new business models and applications.Strategic Focus Areas for BCI Development
- Implantable BCI Devices: Accelerate breakthroughs in high-density sensors, ultra-low-power chips, and brain intention recognition.
- Non-Implantable Devices: Develop new form factors (e.g., forehead patches, ear devices) and integrate BCI into consumer electronics (e.g., smart helmets, glasses).
- BCI Ecosystem: Foster multi-modal integration with other physiological signals and develop high-precision surgical robots.
- Industrial Applications: Drive adoption in fields such as medical rehabilitation, industrial control, and education.
By 2030: Aiming for Global Leadership
- Dramatically enhance the BCI industry’s innovation capabilities.
- Form a secure and reliable industrial system from top to bottom.
- Cultivate 2 to 3 globally influential leading BCI enterprises.
- Build a support system of “specialized, refined, distinctive, and innovative” small and medium-sized companies.
- Create an internationally competitive industrial ecosystem.
- Position China’s overall BCI strength at the forefront of the world.

The Tech Game Plan: Pushing the Limits of BCI
At its core, a brain-computer interface forges a direct communication pathway between the brain and a machine. It’s the ultimate frontier where life science meets information science.
The new policy breaks down the tech push into two main categories: implantable and non-implantable BCIs.
Doubling Down on Implantable BCI R&D
This is where the most ambitious goals lie. The government is calling for accelerated breakthroughs in:
- High-Density Sensors: Developing new products that integrate high-density neural recording sensors.
- Ultra-Low-Power Chips: Innovating ultra-low-power implantable chips.
- Brain Intention Recognition: Improving control precision and response speed for reading brain signals.
- Enhancing Existing Tech: Upgrading mature products like deep brain stimulators, reactive electrical stimulators, and cochlear implants to improve signal accuracy and neurostimulation effectiveness.Non-Implantable BCI Device Design Innovations
- Forehead Patches: Discreet and easy-to-apply designs for monitoring and interaction.
- Ear Patches / In-Ear Devices: Integrated solutions that leverage the ear for signal acquisition.
- Hair Clip-Style BCIs: Innovative form factors for casual and ergonomic use.
- Smart Helmets: Combining protective gear with BCI capabilities for various applications.
- Head-Mounted Displays, Glasses, Headphones: Seamless integration into common consumer electronics for enhanced functionalities.
Scaling Non-Implantable Devices for the Masses
For tech that doesn’t require surgery, the focus is on mass production and better user experience.
- New Form Factors: Innovating product designs like forehead patches, ear patches, in-ear devices, and even hair clip-style BCIs.
- Lightweight & Low-Power: Driving the development of non-implantable products to be lighter, faster, and more power-efficient.
- Consumer Integration: Developing integrated BCI products like smart helmets, head-mounted displays, glasses, and headphones to piggyback on existing consumer electronics.
Building the BCI Ecosystem: Surgical Robots and Auxiliary Gear
A BCI doesn’t work in a vacuum. The plan also includes developing critical support tech:
- Multi-Modal Integration: Combining brain signals (EEG) with other physiological signals like electromyography (muscles), electrooculography (eyes), and electrocardiography (heart) to boost control precision.
- High-Precision Surgical Robots: Creating a new generation of surgical robots for implantable BCIs, capable of sub-micron level precision and real-time 3D imaging during procedures.

Find Top Talent on China's Leading Networks
- Post Across China's Job Sites from $299 / role, or
- Hire Our Recruiting Pros from $799 / role
- Qualified Candidate Bundles
- Lower Hiring Costs by 80%+
- Expert Team Since 2014
Your First Job Post

Follow the Money: How China is Funding its BCI Revolution
A plan is nothing without capital. The policy makes it clear that money will flow.
The government is strengthening support through:
- Major National Projects: Launching a series of large-scale projects to enhance collaborative research.
- Targeted Funding: Encouraging increased investment from the National Manufacturing Transformation and Upgrading Fund and the National Small and Medium-sized Enterprise Development Fund.
- Sci-Tech-Industry-Finance Integration: Implementing special projects to connect capital with BCI innovation, using national industry-finance platforms to attract more private investment.
- Market Access: Providing prioritized registration guidance and support for key products, especially implantable BCI medical devices.
- De-Risking Innovation: Using insurance compensation policies for the “first device” or “first batch” of new technologies to accelerate industrialization.

ExpatInvest China
Grow Your RMB in China:
- Invest Your RMB Locally
- Buy & Sell Online in CN¥
- No Lock-In Periods
- English Service & Data
- Start with Only ¥1,000

From Policy to Practice: BCI Gets Real with Pricing and Trials
This isn’t just talk. The groundwork for commercialization is already being laid.
On March 11, 2025, the National Healthcare Security Administration (国家医保局) established official pricing guidelines for procedures like BCI implantation and removal.
This was quickly followed by concrete action.
On May 12, the Healthcare Security Administration of Zhejiang Province (浙江省医保局) set specific prices:
- Invasive BCI Implantation: ¥6,580 RMB ($900 USD) per procedure.
- Invasive BCI Removal: ¥3,150 RMB ($430 USD) per procedure.
Similar pricing structures are now in place in other key provinces like Hubei (湖北) and Jiangsu (江苏).
On the technology front, in June, China hit a massive milestone.
The Chinese Academy of Sciences (CAS) Center for Excellence in Brain Science and Intelligence Technology (中国科学院脑科学与智能技术卓越创新中心) and Huashan Hospital (复旦大学附属华山医院) successfully ran China’s first prospective clinical trial of an implantable BCI.
This makes China only the second country in the world, after the United States, to reach the clinical trial stage for this advanced technology.

What the Experts Are Saying: Industry Takes on China’s BCI Push
Industry insiders see this as a game-changer.
Ni Changmao (倪常茂), Executive Deputy General Manager of Wuhan Zhonghua Brain-Computer Integration Technology Development Co., Ltd. (武汉衷华脑机融合科技发展有限公司), believes clear pricing is a huge deal.
He says it will act as a “breakthrough for new technology applications, creating new market growth.”
Lan Chunquan (蓝春泉), Vice President of Huafeng Capital (华峰资本), highlights the complexity of the field.
He notes that brain science is a classic interdisciplinary challenge, requiring “seamless cooperation among technology developers, clinical institutions, capital, and government.”
For startups, he advises a careful balancing act: meet short-term survival needs without sacrificing long-term investment in core R&D, especially when facing financial and market pressures.
- Ni Changmao (Wuhan Zhonghua BCI): Views clear pricing as a “breakthrough for new technology applications,” fostering market growth.
- Lan Chunquan (Huafeng Capital): Emphasizes BCI as an interdisciplinary challenge requiring “seamless cooperation” among tech, clinical, capital, and government sectors.
- Lan Chunquan (Huafeng Capital – Advice to startups): Balance short-term survival with long-term R&D investment, especially amid financial and market pressures.

The Big Takeaway: A Pivotal Moment for the Global BCI Industry
This coordinated, multi-departmental push is more than just a signal; it’s a meticulously planned strategy.
With clear goals, dedicated funding channels, and a pathway to commercialization already taking shape, China is not just participating in the BCI race—it’s building a dedicated track to lead it.
This ambitious, dual-driven approach of combining policy with technological acceleration positions China as a formidable force in the future of the brain-computer interface industry.
